BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioNews
Biotechnology, Pharmaceutical and Life Science News
search help

Search Results

Documents 1-25 out of over 1000 found
  Current Search:  slow: 3378, k: 1499     

HTML
55%
Gene discovery may help doctors tailor bowl cancer treatment
A new genetic study has taken scientists a step closer to an era of personalised cancer treatment.British experts identified faults in DNA that can help doctors tailor therapies for thousands of patients with bowel cancer.

The research is the latest to flag...

Yorkshire Evening Post:  Feb 10 2010 4:57AM
Matching: k
Find similar documents
HTML
55%
Bowel cancer treatment breakthrough
A new genetic study has taken scientists a step closer to an era of personalised cancer treatment.

British experts identified faults in DNA that can help doctors tailor therapies for thousands of patients with bowel cancer.

The research is the latest to...

Yahoo! UK and Ireland:  Feb 10 2010 3:25AM
Matching: k
Find similar documents
HTML
55%
Bowel cancer 'hotspots' are found
Bowel cancer is the third most common cancer in the UK Scientists have found genetic hotspots for bowel cancer they say will help doctors better treat the disease.

They say a third of the 37,500 people diagnosed with the cancer in the UK each year harbours...

BBC:  Feb 10 2010 12:03AM
Matching: k
Find similar documents
HTML
55%
DxS Negotiates PI3K License from JHU to Develop Companion Diagnostics
Cancer GEN News Highlights GEN News Highlights QiagensDxS subsidiary negotiated an exclusive global license to the Johns Hopkins University PI3K biomarker patent for use in the development of PCR-based companion diagnostics for cancer therapies.

This license...

Genetic Engineering News:  Feb 9 2010 10:49PM
Matching: k
Find similar documents
HTML
55%
QIAGEN Acquires Exclusive Licence for Key PI3K gene - Patent licensed from Johns Hopkins University for PCR-ba
--- QIAGEN (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced that its wholly owned subsidiary DxS has acquired the global and exclusive licence for biomarker PI3K from Johns Hopkins University to develop real-time-PCR and endpoint PCR assays.
BioPortfolio:  Feb 9 2010 11:47AM
Matching: k
Find similar documents
HTML
55%
QIAGEN Acquires Exclusive Licence for Key PI3K gene
QIAGEN ( NASDAQ:QGEN; Frankfurt Prime Standard: QIA) today announced that its wholly owned subsidiary DxS has acquired the global and exclusive licence for biomarker PI3K from Johns Hopkins University to develop real-time-PCR and endpoint PCR assays.

Research...

RBC Dain Rauscher:  Feb 9 2010 7:20AM
Matching: k
Find similar documents
HTML
55%
QIAGEN acquires global licence for PI3K gene to develop real-time-PCR and endpoint PCR assays
QIAGEN (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced that its wholly owned subsidiary DxS has acquired the global and exclusive licence for biomarker PI3K from Johns Hopkins University to develop real-time-PCR and endpoint PCR assays.

Research...

News-Medical.Net:  Feb 9 2010 4:27AM
Matching: k
Find similar documents
HTML
55%
QIAGEN Acquires Exclusive Licence for Key PI3K gene
VENLO, The Netherlands, February 8 /PRNewswire-FirstCall/ -- QIAGEN (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced that its wholly owned subsidiary DxS has acquired the global and exclusive licence for biomarker PI3K from Johns Hopkins University...
TickerTech.com:  Feb 9 2010 1:54AM
Matching: k
Find similar documents
HTML
55%
QIAGEN Acquires Exclusive Licence for Key PI3K gene
VENLO, The Netherlands, February 8 /PRNewswire-FirstCall/ -- QIAGEN (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced that its wholly owned subsidiary DxS has acquired the global and exclusive licence for biomarker PI3K from Johns Hopkins University...
Yahoo! Canada:  Feb 9 2010 1:31AM
Matching: k
Find similar documents
HTML
55%
QIAGEN Acquires Exclusive Licence for Key PI3K gene
VENLO, The Netherlands, February 8 /PRNewswire-FirstCall/ -- QIAGEN (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced that its wholly owned subsidiary DxS has acquired the global and exclusive licence for biomarker PI3K from Johns Hopkins University...
Red Orbit:  Feb 9 2010 1:12AM
Matching: k
Find similar documents
HTML
55%
QIAGEN Acquires Exclusive Licence for Key PI3K gene
Patent Licensed From Johns Hopkins University for PCR-based Companion Diagnostics for Cancer Treatments VENLO, The Netherlands, February 8/PRNewswire-FirstCall/ -- QIAGEN (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced that its wholly owned...
Pharma Live:  Feb 9 2010 10:07PM
Matching: k
Find similar documents
HTML
55%
Pfizer Q4 2009 Earnings Call Transcript
Pfizer Inc.

(PFE) Q4 2009 Earnings Call Transcript Executives Charles E.

Triano Senior Vice President of IR Jeffrey B.

Kindler Chairman and Chief Executive Officer Frank A.

D''Amelio Senior Vice President and Chief Financial Officer Ian C.

Read -...

123Jump:  Feb 9 2010 3:07PM
Matching: k
Find similar documents
HTML
55%
Pfizer Q4 2009 Earnings Call Transcript
Pfizer Inc.

(PFE) Q4 2009 Earnings Call Transcript Executives Charles E.

Triano Senior Vice President of IR Jeffrey B.

Kindler Chairman and Chief Executive Officer Frank A.

D''Amelio Senior Vice President and Chief Financial Officer Ian C.

Read -...

Ticker:  Feb 9 2010 7:28AM
Matching: k
Find similar documents
HTML
55%
QIAGEN Acquires Exclusive Licence for Key PI3K gene
Patent Licensed From Johns Hopkins University for PCR-based Companion Diagnostics for Cancer Treatments PR Newswire VENLO, The Netherlands, February 8 /PRNewswire-FirstCall/ -- QIAGEN (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced that its wholly...
Dallas Business Chronicle:  Feb 9 2010 5:05AM
Matching: k
Find similar documents
HTML
55%
QIAGEN Acquires Exclusive Licence for Key PI3K gene
Patent Licensed From Johns Hopkins University for PCR-based Companion Diagnostics for Cancer Treatments PR Newswire VENLO, The Netherlands, February 8 /PRNewswire-FirstCall/ -- QIAGEN (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced that its wholly...
Wichita Business Journal:  Feb 9 2010 4:08AM
Matching: k
Find similar documents
HTML
55%
QIAGEN Acquires Exclusive Licence for Key PI3K gene
Patent Licensed From Johns Hopkins University for PCR-based Companion Diagnostics for Cancer Treatments PR Newswire VENLO, The Netherlands, February 8 /PRNewswire-FirstCall/ -- QIAGEN (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced that its wholly...
San Jose Business Journal:  Feb 9 2010 3:38AM
Matching: k
Find similar documents
HTML
55%
QIAGEN Acquires Exclusive Licence for Key PI3K gene
Patent Licensed From Johns Hopkins University for PCR-based Companion Diagnostics for Cancer Treatments PR Newswire VENLO, The Netherlands, February 8 /PRNewswire-FirstCall/ -- QIAGEN (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced that its wholly...
Business Journal of Tampa Bay:  Feb 9 2010 3:09AM
Matching: k
Find similar documents
HTML
55%
QIAGEN Acquires Exclusive Licence for Key PI3K gene
Patent Licensed From Johns Hopkins University for PCR-based Companion Diagnostics for Cancer Treatments PR Newswire VENLO, The Netherlands, February 8 /PRNewswire-FirstCall/ -- QIAGEN (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced that its wholly...
Atlanta Business Chronicle:  Feb 9 2010 2:38AM
Matching: k
Find similar documents
HTML
55%
QIAGEN Acquires Exclusive Licence for Key PI3K gene
Patent Licensed From Johns Hopkins University for PCR-based Companion Diagnostics for Cancer Treatments PR Newswire VENLO, The Netherlands, February 8 /PRNewswire-FirstCall/ -- QIAGEN (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced that its wholly...
San Francisco Business Times:  Feb 9 2010 2:08AM
Matching: k
Find similar documents
HTML
55%
QIAGEN Acquires Exclusive Licence for Key PI3K gene
Patent Licensed From Johns Hopkins University for PCR-based Companion Diagnostics for Cancer Treatments PR Newswire VENLO, The Netherlands, February 8 /PRNewswire-FirstCall/ -- QIAGEN (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced that its wholly...
San Antonio Business Journal:  Feb 9 2010 1:50AM
Matching: k
Find similar documents
HTML
55%
QIAGEN Acquires Exclusive Licence for Key PI3K gene
(PR Newswire Europe via COMTEX) ----Patent Licensed From Johns Hopkins University for PCR-based Companion Diagnostics for Cancer Treatments QIAGEN (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced that its wholly owned subsidiary DxS has acquired...
FOXBusiness.com:  Feb 9 2010 1:47AM
Matching: k
Find similar documents
HTML
55%
QIAGEN Acquires Exclusive Licence for Key PI3K gene - Zibb.com
Company: Qiagen N.V.

(QGEN) Patent Licensed From Johns Hopkins University for PCR-based Companion Diagnostics for Cancer Treatments QIAGEN (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced that its wholly owned subsidiary DxS has acquired the...

Zibb:  Feb 9 2010 1:23AM
Matching: k
Find similar documents
HTML
55%
QIAGEN Acquires Exclusive Licence for Key PI3K gene
Patent Licensed From Johns Hopkins University for PCR-based Companion Diagnostics for Cancer Treatments PR Newswire VENLO, The Netherlands, February 8 /PRNewswire-FirstCall/ -- QIAGEN (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced that its wholly...
Charlotte Business Journal:  Feb 9 2010 1:14AM
Matching: k
Find similar documents
HTML
55%
QIAGEN Acquires Exclusive Licence for Key PI3K gene
Patent Licensed From Johns Hopkins University for PCR-based Companion Diagnostics for Cancer Treatments PR Newswire VENLO, The Netherlands, February 8 /PRNewswire-FirstCall/ -- QIAGEN (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced that its wholly...
St Louis Business Journal:  Feb 9 2010 1:10AM
Matching: k
Find similar documents
HTML
55%
QIAGEN Acquires Exclusive Licence for Key PI3K gene
Patent Licensed From Johns Hopkins University for PCR-based Companion Diagnostics for Cancer Treatments PR Newswire VENLO, The Netherlands, February 8 /PRNewswire-FirstCall/ -- QIAGEN (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced that its wholly...
Cincinnati Business Journal:  Feb 9 2010 1:07AM
Matching: k
Find similar documents


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.